[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4963 followers
Created: 2025-07-20 19:33:29 UTC

🦉 Eight GLP-1RAs approved for T2DM; two for obesity. Short-acting agents mainly slow gastric emptying; long-acting forms regulate both basal and postprandial glucose. Half-life affects efficacy.

#GLP1 #diabetes $NVO $LLY $AZN $VKTX $SNY $GSK $PFE


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947017035193401826/c:line.svg)

**Related Topics**
[pfe](/topic/pfe)
[manat](/topic/manat)
[$gsk](/topic/$gsk)
[$sny](/topic/$sny)
[$lly](/topic/$lly)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)

[Post Link](https://x.com/AponiaAnalytics/status/1947017035193401826)